Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Virology

Background:

• Developing small molecule inhibitors of protein-protein interactions is a promising strategy for anti-HIV-1 therapies.
• Previous computational studies identified inhibitors targeting the interaction between HIV-1 integrase (IN) and LEDGF/p75.

Purpose of the Study:

• To elucidate the binding site of LEDGF/p75 on IN using a distinct computational approach.
• To identify structural requirements for disrupting the LEDGF/p75-IN interaction.
• To explore the role of a hydrophobic region in inhibitor efficacy.

Main Methods:

• Employed a novel computational approach to investigate the LEDGF/p75-IN binding site.
• Performed chemical modifications on previously identified 'hit' compounds.
• Synthesized new compounds and evaluated their biological activity.

Main Results:

• Identified a significant hydrophobic region within the LEDGF/p75-IN binding interface.
• Demonstrated that chemical modifications targeting this hydrophobic pocket enhance inhibitory efficacy.
• Synthesized compounds showed improved inhibitory potential against HIV-1.

Conclusions:

• The hydrophobic pocket plays a critical role in the efficacy of LEDGF/p75-IN inhibitors.
• These findings provide new insights for designing potent anti-HIV-1 ligands.
• This research advances the development of novel therapeutic strategies against HIV-1.